Reuters Health Report

Click to View in Browser 03/6/2014 Gene therapy may offer 'functional' cure for HIV (Reuters) - A strategy to genetically modify cells from people infected with HIV could become a way to control the virus that causes AIDS without using antiviral drugs, according to results from an early-stage trial that were published on Wednesday. FDA approves Endo International's testosterone drug (Reuters) - Endo International Plc said the U.S. Food and Drug Administration approved its thrice-rejected testosterone replacement therapy, Aveed, to treat male hypogonadism. U.S. fears for patents on next-generation drugs in India NEW DELHI/MUMBAI (Reuters) - The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on patent. U.S. House votes to delay Obamacare penalty for non-enrollment WASHINGTON (Reuters) - The Republican-led U.S. House of Representatives voted on Wednesday to delay for one year the tax penalty Americans will pay under President Barack Obama's healthcare law if they decline to enroll in health coverage. When tribes build casinos, obesity falls in youth NEW YORK (Reuters Health) - After American Indians built casinos on California tribal lands, their incomes rose and their children's obesity rates fell, according to a new study. Washington state issues first pot-growing license OLYMPIA, Washington (Reuters) - Marijuana regulators issued Washington state's first business license for recreational cannabis on Wednesday to a grower who said he expects to have blooming pot plants ready to harvest within eight weeks. U.S. health plans that don't meet Obamacare rules can renew for two more years WASHINGTON (Reuters) - The Obama administration on Wednesday said it would allow health insurers to extend plans that fail to comply with its signature health law for an additional two years, a move Republicans quickly condemned as a politically motivated delay. Italian watchdog says Novartis, Roche colluded over eye drug ZURICH/MILAN (Reuters) - Italy's antitrust authorities said Swiss drugmakers Novartis and Roche colluded to try to stop cancer drug Avastin being used to treat a serious eye disease, and fined the companies 182.5 million euros ($251 million). Florida legislature joins southern push for marijuana reform TALLAHASSEE, Florida (Reuters) - Acknowledging a major shift in societal attitudes toward marijuana, a key committee of the Florida legislature voted overwhelmingly on Wednesday to approve medical use of a "non-euphoric" marijuana extract that has shown promising results in treating seizures. Nine-month-old baby may have been cured of HIV, U.S. scientists say BOSTON (Reuters) - A 9-month-old baby who was born in California with the HIV virus that leads to AIDS may have been cured as a result of treatments that doctors began just four hours after her birth, medical researchers said on Wednesday. Related Video Bringing U.S. fracking know-how to U.K. shale Green group seeking common ground at energy forum The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend